Are ReLume and IPL Treatments FDA-cleared?
ReLume was FDA-cleared to market in 2002 for the treatment of leukoderma, or skin conditions in which pigment loss has occurred. Patented IPL technology has been available and FDA-cleared since 1995. IPL treatments using the Photorejuvenation process are recognized as safe, effective, and high in patient satisfaction. In addition to treatment of benign vascular and pigmented conditions, scar treatments are included in the IPL FDA clearance.
